InfuSystem Q1 revenue $34.7M (+9% YoY); Adj. EBITDA $6.3M (+64%)

InfuSystem Holdings, Inc

2025-Q1 EPS reported -$0.01 revenue$34,716,000

Net revenue $34.7M (+9% YoY); net loss narrowed to $0.3M ($0.01 loss per share) from $1.1M.
Adjusted EBITDA $6.3M (+64% YoY); margin expanded 6.2pp to 18.2%.
Patient Services revenue up 12% to $20.8M; Device Solutions up 4% to $13.9M.
FY 2025 guidance reaffirmed: revenue growth 8-10%; Adj. EBITDA margin high teens.
CEO transition: Richard DiIorio out; Carrie Lachance (COO) incoming; $1.0M severance accrued.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.